SCN5A

Chr 3ARAD

sodium voltage-gated channel alpha subunit 5

Also known as: CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD

The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]

Primary Disease Associations & Inheritance

{Sudden infant death syndrome, susceptibility to}MIM #272120
AR
Atrial fibrillation, familial, 10MIM #614022
AD
Brugada syndrome 1MIM #601144
AD
Cardiomyopathy, dilated, 1EMIM #601154
AD
Heart block, nonprogressiveMIM #113900
AD
Heart block, progressive, type IAMIM #113900
AD
Long QT syndrome 3MIM #603830
AD
Sick sinus syndrome 1MIM #608567
AR
Ventricular fibrillation, familial, 1MIM #603829
UniProtProgressive familial heart block 1A
UniProtFamilial paroxysmal ventricular fibrillation 1
UniProtAtrial standstill 1
0
Active trials
51
Pathogenic / LP
439
ClinVar variants
6
Pubs (1 yr)
2.8
Missense Z
0.31
LOEUF· LoF intolerant
Clinical SummarySCN5A
🧬
Gene-Disease Validity (ClinGen)
arrhythmogenic right ventricular cardiomyopathy · ADLimited

Limited evidence — not for standalone diagnostic reporting

4 total gene-disease associations curated

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.91). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
51 Pathogenic / Likely Pathogenic· 270 VUS of 439 total submissions
📖
GeneReview available — SCN5A
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

ensembl: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.31LOEUF
pLI 0.913
Z-score 6.70
OE 0.21 (0.140.31)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
2.75Z-score
OE missense 0.78 (0.740.82)
967 obs / 1239.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.21 (0.140.31)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.78 (0.740.82)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.98
01.21.6
LoF obs/exp: 17 / 82.8Missense obs/exp: 967 / 1239.5Syn Z: 0.34
DN
0.6744th %ile
GOF
0.81top 10%
LOF
0.3842th %ile

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function, gain-of-function and dominant-negative). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF1 literature citation · 49% of P/LP variants are LoF · LOEUF 0.31
GOFprediction above median · 1 literature citation
DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNIn co-expression experiments, L325R channels interfered with the proper function of WT channels, suggesting that a dominant negative phenomenon may underlie BrS triggered by fever.PMID:15890323
GOFA heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.PMID:23840796
LOFThey also demonstrate that haploinsufficiency of SCN5A is associated with increased accumulation of reactive oxygen species (ROS) in a genetically engineered murine model.PMID:29457788

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

439 submitted variants in ClinVar

Classification Summary

Pathogenic30
Likely Pathogenic21
VUS270
Likely Benign115
Conflicting3
30
Pathogenic
21
Likely Pathogenic
270
VUS
115
Likely Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
15
0
15
0
30
Likely Pathogenic
10
6
5
0
21
VUS
5
238
22
5
270
Likely Benign
0
4
42
69
115
Benign
0
0
0
0
0
Conflicting
3
Total302488474439

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SCN5A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

SCN5A-related long QT syndrome

definitive
ADGain Of FunctionAltered Gene Product Structure
Cardiac
G2P ↗
missense variantinframe deletioninframe insertion

SCN5A-related Brugada syndrome

definitive
ADLoss Of FunctionAltered Gene Product Structure, Decreased Gene Product Level
Cardiac
G2P ↗
splice region variantsplice acceptor variantsplice donor variantframeshift variantstop gainedmissense variantinframe deletioninframe insertionstop gained NMD triggeringframeshift variant NMD triggering

SCN5A-related arrhythmogenic right ventricular cardiomyopathy

limited
ADUndeterminedUncertain
Cardiac
G2P ↗

SCN5A-related dilated cardiomyopathy

definitive
ADUndeterminedAltered Gene Product Structure, Decreased Gene Product Level
Cardiac
G2P ↗
missense variantstop gained NMD triggering

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗